The price of Liertinib (the exact name is subject to verification, as there may be a misstatement) has not been uniformly set and publicly announced. Its cost varies depending on factors including dosage form, region, purchase channel and medical insurance policy, with the price of a single vial (or box) generally ranging from several hundred to several thousand yuan. As a prescription-only medicine, it must be used strictly in accordance with the doctor’s instructions, and shall not be purchased or dosed without medical guidance.
Factors Affecting the Price
Dosage and Packaging Differences
Price variations arise from different dosages (e.g., 100mg/vial, 50mg/vial) or package sizes (e.g., 10 tablets/box, 30 tablets/box).
Purchase Channels
Prices may differ between hospital pharmacies, designated retail pharmacies and online platforms. In regions where Liertinib is covered by medical insurance, the out-of-pocket cost for patients is significantly reduced.
Regional Policies
Reimbursement rates under medical insurance, drug procurement policies and subsidy intensity vary across provinces and cities. It is recommended to consult local medical institutions for details.
Medication Precautions
Prescription Compliance
Liertinib is available only with a doctor’s prescription. Before administration, relevant examinations (e.g., gene testing) must be completed to confirm that the patient meets the medication indications.
Adverse Effect Management
Adverse reactions such as rash and diarrhea may occur. Patients are required to attend regular follow-ups and report any physical changes to their doctors, who will then adjust the treatment plan accordingly.
Storage and Administration
The medicine must be stored away from light. It should be taken regularly and in the prescribed dosage as instructed in the package insert or by the doctor to avoid missing doses or accidental overdosing.
Cost Reduction Options
Medical Insurance Reimbursement
Liertinib has been included in the critical illness insurance scheme or special drug catalog in some provinces and cities, with a reimbursement rate of 50% to 70%.
Charitable Assistance
Certain pharmaceutical companies or foundations offer patient assistance programs, through which eligible patients can apply for free or low-cost medications.
For the exact price, patients are advised to bring their prescription to a hospital or licensed pharmacy for consultation, and verify the accuracy of the drug name (e.g., confirm whether it refers to Erlotinib or other drugs with similar names). Concurrent use of other medications without medical advice should be avoided to prevent potential drug interactions.
